NovoCure (NVCR) SEC Filings & 10K Form

$12.64
+0.40 (+3.27%)
(As of 04/26/2024 ET)

Recent NovoCure SEC Filings

DateFilerForm TypeView
03/27/2024
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
5:39 PM
NovoCure (Subject)
Shah Pritesh (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
5:17 PM
GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
3:43 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:33 PM
Giladi Moshe (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:33 PM
Leupin Nicolas (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:35 PM
NovoCure (Issuer)
Weinberg Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
6:11 AM
NovoCure (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/22/2024
6:05 AM
NovoCure (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2024
6:06 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
8:28 AM
FMR LLC (Filed by)
NovoCure (Subject)
Form SC 13G/A
01/18/2024
6:01 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2024
3:57 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/11/2024
4:15 PM
Leupin Nicolas (Reporting)
NovoCure (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/09/2024
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
6:10 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
3:10 PM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
3:23 PM
Giladi Moshe (Reporting)
NovoCure (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/11/2023
5:19 AM
Capital World Investors (Filed by)
NovoCure (Subject)
Form SC 13G/A
11/28/2023
6:30 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
5:15 AM
BAILLIE GIFFORD & CO (Filed by)
NovoCure (Subject)
Form SC 13G/A
11/08/2023
3:22 PM
NovoCure (Issuer)
Shah Pritesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2023
4:15 PM
NovoCure (Issuer)
Puri Michal Nath (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/02/2023
3:20 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2023
6:02 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/26/2023
6:03 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2023
3:23 PM
NovoCure (Issuer)
Shah Pritesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
3:24 PM
GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
3:24 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
3:40 PM
Cordova Ashley (Reporting)
NovoCure (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2023
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/27/2023
6:02 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/27/2023
6:03 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2023
7:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/06/2023
3:12 PM
Danziger Asaf (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:13 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:13 PM
Ben Arye Barak (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:14 PM
Burke William Patrick (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:14 PM
NovoCure (Issuer)
Shah Pritesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:14 PM
GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:15 PM
NovoCure (Issuer)
Weinberg Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Did You Get Your Free Bitcoin Yet? (Ad)

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here
06/06/2023
2:45 PM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2023
11:18 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2023
7:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2023
3:34 PM
NovoCure (Issuer)
Stafford Kristin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
6:02 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2023
6:02 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:NVCR) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners